TY - JOUR
T1 - PAX2 Mutation-Related Renal Hypodysplasia
T2 - Review of the Literature and Three Case Reports
AU - Chang, Yu Ming
AU - Chen, Chih Chia
AU - Lee, Ni Chung
AU - Sung, Junne Ming
AU - Chou, Yen Yin
AU - Chiou, Yuan Yow
N1 - Funding Information:
We thank the Center for Allergy and Clinical Immunology Research (ACIR), National Cheng Kung University, Tainan, Taiwan for assisting with the publication of this study.
Publisher Copyright:
Copyright © 2022 Chang, Chen, Lee, Sung, Chou and Chiou.
PY - 2022/1/11
Y1 - 2022/1/11
N2 - Paired box 2 (PAX2)-related disorder is an autosomal dominant genetic disorder associated with kidney and eye abnormalities and can result in end stage renal disease (ESRD). Despite reported low prevalence of PAX2 mutations, the prevalence of PAX2 related disorders may have been underestimated in past studies. With improved genetic sequencing techniques, more genetic abnormalities are being detected than ever before. Here, we report three patients from two families with PAX2 mutations identified within 1 year. Two patients were adults with chronic kidney disease and were followed for decades without correct diagnoses, including one with ESRD who had even undergone kidney transplant. The third patient was a neonate in whom PAX2-related disorder manifested as oligohydramnios, coloboma, and renal failure that progressed to ESRD within 1 year after birth. The phenotypes of PAX2 gene mutation were shown to be highly variable, even within the same family. Early detection promoted genetic counseling and guided clinical management. The appropriate time point for genetic study is an important issue. Clinicians must be more alert for PAX2 mutation when facing patients with congenital kidney and urinary tract anomalies, chronic kidney disease of unknown etiology, involvement of multiple systems, and/or a family history of renal disease.
AB - Paired box 2 (PAX2)-related disorder is an autosomal dominant genetic disorder associated with kidney and eye abnormalities and can result in end stage renal disease (ESRD). Despite reported low prevalence of PAX2 mutations, the prevalence of PAX2 related disorders may have been underestimated in past studies. With improved genetic sequencing techniques, more genetic abnormalities are being detected than ever before. Here, we report three patients from two families with PAX2 mutations identified within 1 year. Two patients were adults with chronic kidney disease and were followed for decades without correct diagnoses, including one with ESRD who had even undergone kidney transplant. The third patient was a neonate in whom PAX2-related disorder manifested as oligohydramnios, coloboma, and renal failure that progressed to ESRD within 1 year after birth. The phenotypes of PAX2 gene mutation were shown to be highly variable, even within the same family. Early detection promoted genetic counseling and guided clinical management. The appropriate time point for genetic study is an important issue. Clinicians must be more alert for PAX2 mutation when facing patients with congenital kidney and urinary tract anomalies, chronic kidney disease of unknown etiology, involvement of multiple systems, and/or a family history of renal disease.
UR - http://www.scopus.com/inward/record.url?scp=85123410342&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123410342&partnerID=8YFLogxK
U2 - 10.3389/fped.2021.765929
DO - 10.3389/fped.2021.765929
M3 - Article
AN - SCOPUS:85123410342
SN - 2296-2360
VL - 9
JO - Frontiers in Pediatrics
JF - Frontiers in Pediatrics
M1 - 765929
ER -